Act4Biosimilars aims to increase patient access to advanced medicines by facilitating greater approvability, accessibility, acceptability and affordability (the four A’s) of biosimilars.
Byooviz is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion and myopic choroidal neovascularization.
Pemetrexed Lyo. Injection is used to treat non-squamous non-small cell lung cancer and malignant pleural mesothelioma, a cancer of the inside lining of the chest cavity.
Said Darwazah, Hikma’s executive chairman and former CEO, will assume all CEO responsibilities; Hikma’s board has initiated the process to identify a new CEO.